ANCA vasculitis in the elderly

Journal of Clinical Rheumatology

Volumn 14, Issue 2, 2008, Pages 78-81

  Hoganson, Deana D ^a   From, Aaron M ^a   Michet Jr , Clement J ^a  

^a MAYO CLINIC   (United States)

Author keywords

ANCA; Elderly; Microscopic polyangiitis; Vasculitis; Wegener granulomatosis

Indexed keywords

CREATININE; HEMOGLOBIN;

ADULT; AGED; ANCA ASSOCIATED VASCULITIS; ARTICLE; BLOOD VESSEL BIOPSY; CAUSE OF DEATH; CLINICAL FEATURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; LUNG BIOPSY; MAJOR CLINICAL STUDY; MALE; MICROSCOPIC POLYANGIITIS; MORTALITY; PRIORITY JOURNAL; SCORING SYSTEM; SKIN BIOPSY; SURVIVAL RATE; WEGENER GRANULOMATOSIS;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MINNESOTA; SEVERITY OF ILLNESS INDEX; SEX FACTORS; WEGENER GRANULOMATOSIS;

EID: 42049090456     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/RHU.0b013e31816b2fbd     Document Type: Article

References (19)

1. Watts RA, Lane S, Bentham G, et al. Epidemiology of systemic vasculitis: a ten-year study in the United Kingdom. Arthritis Rheum. 2000;43:414-419.
2. Watts RA, Scott DG. Epidemiology of the vasculitides. Curr Opin Rheumatol. 2003;15:11-16.
3. Tidman M, Olander R, Svalander C, et al. Patients hospitalized because of small vessel vasculitides with renal involvement in the period 1975-95: organ involvement, anti-neutrophil cytoplasmic antibodies patterns, seasonal attack rates and fluctuation of annual frequencies. J Intern Med. 1998;244:133-141.
4. Scott DG, Watts RA. Classification and epidemiology of systemic vasculitis. Br J Rheumatol. 1994;33:897-899.
5. Jayne D, Rasmussen N, Andrassy K, et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic antibodies. NEJM. 2003;349:36-44.
6. Lane SE, Watts RA, Shepstone L, et al. Primary systemic vasculitis: clinical features and mortality. Q J Med. 2005;98:97-111.
7. Vassallo M, Shepard RJ, Iqbal P, et al. Age-related variations in presentation and outcome in Wegener's granulomatosis. J RCP. 1997;31:396-400.
8. Pavone L, Grasselli C, Chierici E, et al. Outcome and prognostic factors during the course of primary small-vessel vasculitides. J Rheumatol. 2006;33:1299-1306.
9. Mahr A, Girard T, Agher R, et al. Analysis of factors predictive of survival based on 49 patients with systemic Wegener's granulomatosis and prospective follow-up. Rheumatology. 2001;40:492-498.
10. Slot MC, Tervaert JW, Franssen CF, et al. Renal survival and prognostic factors in patients with PR3-ANCA associated vasculitis with renal involvement. Kidney Int. 2003;63:670-677.
11. Booth AD, Almond MK, Burns A, et al. Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study. Am J Kidney Dis. 2003;41:776-784.
12. Leavitt RY, Fauci AS, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum. 1990;33:1101-1107.
13. Jennette JC, Falk R, Andrassy K, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 1994;37:187-192.
14. Luqmani RA, Bacon PA, Moots RJ, et al. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. Q J Med. 1994;87:671-678.
15. Krafcik SS, Covin RB, Lynch JP, et al. Wegener's granulomatosis in the elderly. Chest. 1996;109:430-437.
16. Little MA, Nazar L, Farrington K. Polymyalgia rheumatica preceding small-vessel vasculitis: changed spots or misdiagnosis? Q J Med. 2004;97:289-292.
17. Stone JH. Wegener's Granulomatosis Etanercept Trial Research Group. Limited versus severe Wegener's granulomatosis: baseline data on patients in the Wegener's granulomatosis etanercept trial. Arthritis Rheum. 2003;48:2299-2309.
18. Harper L, Savage CO. ANCA-associated renal vasculitis at the end of the twentieth century-a disease of older patients. Rheumatology. 2005;44:495-501.
19. Franssen CF, Stegeman CA, Kallenberg CG, et al. Antiproteinase 3- and antimyeloperoxidase-associated vasculitis. Kidney Int. 2000;57:2195-2206.